The Latest Breaking News from Beam

The purple e-bikes will be joined by e-scooters in Lake Macquarie.

Transport agency Waka Kotahi is still debating how to measure the maximum power output, the High Court warns.

Here's a roundup of top developments in the biotech space over the last 24 hours:

£1,408 was raised in 11 days through donations from over 50 members of the public.

The rental e-scooter craze is sweeping the globe, with millions of the vehicles dotting pavements in more than 600 cities. Studies predict there will be 4.6 million shared e-scooters in operation worldwide by 2024.

With rising petrol prices and environmental concerns, e-scooters are quickly growing in popularity. But as legislation lags, are they safe?

Our round-up of stories this week includes Ocado Retail, Hay &Kilner, the North East BIC and durhamlane

BMO Capital initiated coverage on Beam Therapeutics Inc (NASDAQ:BEAM) with a Market Perform rating and a price target of 41. BMO writes that it appreciates the high potential of Beam's next-generation editing approach, but clinical validation is yet to be established. Preclinical base editing data point to a favorable benefit/risk profile. Also Read: Pfizer, Beam…

A start date has not been set, but organisers plan to have them ready to use by the end of this month.